| Long name: |
Adracalin Primary Polyclonal Antibody |
| Also known as: |
Adracalin PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
Adracalin |
| Specificity: |
This is a highly specific antibody against Adracalin |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human Adracalin |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Aladin plays a role in peripheral and central nervous system development, Defects in Aladin cause the autosomal recessive disorder achalasia-addisonianism-alacrima (triple A) syndrome, It is widely expressed, RNA processing and transcription, Robust expression in neural systems associated with cognitive, These proteins have a wide variety of functions, Triple A syndrome is characterized by achalasia, adrenal gland and gastrointestinal structures, alacrima and adrenocortico-tropin-resistant adrenal insufficiency, cerebellum, corpus callosum, including signal transduction regulation, motor and sensory functions is consistent with the myriad of symptoms experienced by patients with triple A syndrome, with the highest expression seen in pituitary gland, Aladin (Adracalin) belongs to a family of WD repeat-containing proteins |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
AAAS, AAAS_HUMAN, AAASb, ADRACALA, Achalasia adrenocortical insufficiency alacrimia, Achalasia adrenocortical insufficiency alacrimia Allgrove triple A, Aladin, Allgrove triple A, DKFZp586G1624, GL003, AAA |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
Adracalin |
| Short name: |
Adracalin Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Adracalin (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
13666 |
| Gene: |
AAAS |
More about : AAAS |
| Long gene name: |
aladin WD repeat nucleoporin |
| Synonyms gene name: |
achalasia, adrenocortical insufficiency, adrenocortical insufficiency, alacrimia , alacrimia (Allgrove, triple-A) achalasia |
| Synonyms name: |
aladin Allgrove, triple-A adracalin |
| Locus: |
12q13, 13 |
| Discovery year: |
2000-11-08 |
| GenBank acession: |
AJ289841 |
| Entrez gene record: |
8086 |
| Pubmed identfication: |
11062474 |
| Classification: |
Nucleoporins WD repeat domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000169729 |